Oxford Biomedica completes €68m sale & leaseback of Windrush Court

UK-based gene and cell therapy group Oxford Biomedica has sold its Windrush Court facility in Oxford to Kadans Science Partner for £60 mln (€68 mln).

Premium subscriber content – please log in to read more or take a free trial.
img
Editor
Profile

Events

Latest news

Best read stories

About PropertyEU

Who are we? PropertyEU was established in 2006 as a truly pan-European information source for real estate professionals. We provide in-depth news, data and analysis of Europe's property markets at a time of increasing cross-border investment, development and financing across the continent and beyond.

Contact information

Office address

Prins Bernhardplein 173
1097 BL Amsterdam

Phone

General:
+31 (0)88 776 73 78

Our media channels

Top
© Copyright PropertyEU 2024.